William M. Womack, M.D.
Name, Degree: William M. Womack, M.D.
Role(s) in Task Force and Work Group: Member, DSM-V Task Force
Institutional Affiliation(s): Associate Professor; Director, Continuing Medical Education Program, Division of Child Psychiatry Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine
City, State: Seattle, WA
Biographical Sketch:
Dr. Womack is an academic child psychiatrist with diverse clinical experience across the spectrum of childhood and adolescent disorders. As former chief of the Division of Child and Adolescent Psychiatry, he has extensive administrative experiences, with responsibility for developing and directing new clinical programs in the academic setting, and being physician manager for quality improvement efforts within the context of a juvenile offender state program. Dr. Womack has been active for many years in the governance structure of the American Psychiatric Association and the American Academy of Child and Adolescent Psychiatry. He is an advocate for children and adolescents; juvenile offenders; lesbians, gays, bisexuals, and transgendered; and racial and ethnic minorities.
Uncompensated affiliations with non-profit or advocacy organizations that may have a direct or indirect interest in psychiatric diagnosis, treatment, or the DSM-V : Three calendar years before nomination and Each year thereafter through the present calendar year. (For 2008, activities to date and commitments for remainder of year.)
|
Non-Profit and Advocacy Organizations |
Year(s) |
Role |
|
American Psychiatric Association |
1991-present |
Assembly Liaison, Council on Children, Adolescents and Families; |
|
American Academy of Child and Adolescent Psychiatry |
1985-1991 |
Member, Council |
The two tables below represent Dr. Womack’s disclosure of significant interests and affiliations for: (1) The time period including the 3 years prior to nomination to serve on the DSM-V Task Force; the calendar year in which nomination to the Task Force occurred; through the calendar year in which the nomination was approved; and (2) the time period including the calendar year after approval, and each successive year to the present.
Dr. Womack has agreed that, from the time of approval through the publication of DSM-V, projected in 2012, his aggregate annual income derived from industry sources (excluding unrestricted research grants) will not exceed $10,000 in any calendar year.
|
KEY NUMBER:
1. Consultation Fees (include scientific advisory boards)
2. Full- or Part-time Employee
3. Industry-related Grant-Research Support received or pending
4. Honoraria (includes Speakers’ Bureau)
5. Stock or other financial options |
6. Expert testimony
7. Royalties (including right to share of revenue or profit from pharmaceutical, device or other development or product)
8. Patents received or pending
9. Officer, director/trustee, executive (specify)
10. Other (specify) |
Disclosure of significant interests including: Three (3) calendar years before nomination, the calendar year of nomination, through the calendar year of approval to serve on the DSM-V Task Force
|
Commercial or Other Organization |
Year(s) |
Key #(s) |
|
None |
|
|
Disclosure of significant interests Beginning with the calendar year after APA Board of Trustees approval to serve on the DSM-V Task Force, to the present. (For 2008, activities to date and commitments for remainder of year.)
|
Commercial or Other Organization |
Year(s) |
Key #(s) |
|
None |
|
|